Medicare Enrolled
Dr. Joseph Stuckert, M.D.
Dermatology · Pittsburgh, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Stuckert from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stuckert?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Stuckert
Dr. Joseph Stuckert is a dermatology specialist in Pittsburgh, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Stuckert performed 2,474 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Stuckert received a total of $6,523 from 39 pharmaceutical and/or device companies across 339 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Stuckert is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 39% volume in PA
$6,523 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,474
Medicare services
Top 39% in PA for dermatology
Not available
Unique patients (not deduplicated)
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
860 | $5 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
457 | $58 | $227 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
265 | $82 | $302 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
261 | $37 | $168 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
178 | $78 | $279 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
151 | $61 | $247 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
75 | $62 | $261 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
46 | $38 | $123 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
43 | $76 | $425 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
30 | $49 | $216 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
25 | $176 | $627 |
| Destruction of skin growth, 15 or more growths | 24 | $97 | $347 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
17 | $233 | $798 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
17 | $124 | $414 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $84 | $432 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
12 | $72 | $460 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,523
Total received (2018-2024)
Avg $932/year across 7 years
Top 24% in PA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
339
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,796
2023
$613
2022
$158
2021
$167
2020
$114
2019
$40
2018
$2,636
Payments by company (2024)
ABBVIE INC.
$549
GENZYME CORPORATION
$262
Janssen Biotech, Inc.
$227
UCB, Inc.
$226
Ascensia Diabetes Care Us Inc.
$217
SUN PHARMACEUTICAL INDUSTRIES INC.
$205
PFIZER INC.
$203
Novartis Pharmaceuticals Corporation
$190
Incyte Corporation
$149
LEO Pharma Inc.
$112
E.R. Squibb & Sons, L.L.C.
$102
Regeneron Healthcare Solutions, Inc.
$98
NOBELPHARMA AMERICA, LLC
$46
Journey Medical Corporation
$39
Dermavant Sciences, Inc.
$37
Lilly USA, LLC
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Verrica Pharmaceuticals Inc.
$20
Arcutis Biotherapeutics, Inc.
$19
Amgen Inc.
$13
Biofrontera Inc.
$12
Top 3 companies account for 37.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$655
ABBVIE INC.
$549
AbbVie, Inc.
$498
Journey Medical Corporation
$427
Novartis Pharmaceuticals Corporation
$390
PFIZER INC.
$383
GENZYME CORPORATION
$336
E.R. Squibb & Sons, L.L.C.
$300
UCB, Inc.
$251
Incyte Corporation
$245
Ascensia Diabetes Care Us Inc.
$217
SUN PHARMACEUTICAL INDUSTRIES INC.
$205
Ortho Dermatologics, a division of Bausch Health US, LLC
$195
LEO Pharma Inc.
$191
Lilly USA, LLC
$174
Regeneron Healthcare Solutions, Inc.
$153
Mayne Pharma Inc.
$137
Biofrontera Inc.
$127
Novum Pharma, LLC
$115
Promius Pharma LLC
$112
Bayer HealthCare Pharmaceuticals Inc.
$102
EPI Health, LLC
$95
Dermavant Sciences, Inc.
$78
Sun Pharmaceutical Industries Inc.
$74
Amgen Inc.
$64
Galderma Laboratories, L.P.
$61
NOBELPHARMA AMERICA, LLC
$46
Genentech USA, Inc.
$45
Almirall LLC
$44
DUSA Pharmaceuticals, Inc.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Taro Pharmaceuticals USA, Inc.
$32
Kyowa Kirin, Inc.
$31
PruGen, Inc. Pharmaceuticals
$25
Verrica Pharmaceuticals Inc.
$20
Sandoz Inc.
$20
Arcutis Biotherapeutics, Inc.
$19
Mylan Pharmaceuticals Inc.
$18
AbbVie Inc.
$15
Top 3 companies account for 26.1% of all-time payments
Associated products mentioned in payments ›
20% · ABSORICA (isotretinoin) · ADBRY · AMELUZ · Alcortin A · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · Bensal HP · Bimzelx · CIBINQO · COSENTYX · CYLTEZO · Ceracade · Cimzia · Cloderm Cream · DERMATITIS - DISEASE · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EUCRISA · EVERSENSE 365 SENSOR KIT (RETAIL) · Enbrel · Erivedge · FINACEA · Finacea · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HYFTOR · Humira · ILUMYA · JUBLIA EFINACONAZOLE · KERYDIN · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Otezla · POTELIGEO · QUINJA · REMICADE · RETIN-A-MICRO · RINVOQ · SKYRIZI · SOLODYN · SOOLANTRA · STELARA · Sernivo Spray · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · USP) 0.1% · VTAMA · Veltin · Winlevi · XOLAIR · YCANTH · Zonalon · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
88
County median income
$76,393
Nearest hospital to ZIP centroid (approximate)
UPMC PASSAVANT
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Stuckert is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Stuckert experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Stuckert performed 860 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Stuckert receive payments from pharmaceutical companies?
Yes. Dr. Stuckert received a total of $6,523 from 39 companies across 339 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stuckert's costs compare to other dermatologists in Pittsburgh?
Dr. Stuckert's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stuckert) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Pittsburgh
Browse dermatologists in Pittsburgh ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in PA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in PA
Which PA dermatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology